Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients

Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients

Abstract Introduction Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare demyelinating disorder of the central nervous system. Despite increased recognition of MOGAD as a distinct disease and the availability of sensitive methods of MOG antibody testing, diagnostic cha...

Full description

Bibliographic Details
Main Authors: Jonathan D. Santoro, Jennifer Gould, Zoya Panahloo, Ella Thompson, Julia Lefelar, Jacqueline Palace
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-04-01
Series:Neurology and Therapy
Subjects:
Demyelination
Diagnosis
Myelin oligodendrocyte glycoprotein (MOG)
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)
Neurology
Patient perspective
Online Access:https://doi.org/10.1007/s40120-023-00474-9

Internet

https://doi.org/10.1007/s40120-023-00474-9

Similar Items